Cimpress (CMPR) Financials

$89.52 -2.31 (-2.52%)

Closing price 05/6/2026 04:00 PM Eastern

Extended Trading

$89.48 -0.03 (-0.04%)

As of 05/6/2026 05:44 PM Eastern

Annual Income Statements for Cimpress

This table shows Cimpress' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	92	54	-72	44	95	83	-85	-54	-186	174	15
Consolidated Net Income / (Loss)	89	50	-72	47	93	84	-82	-51	-186	178	13
Net Income / (Loss) Continuing Operations	89	50	-72	47	93	185	-82	-51	-186	178	13
Total Pre-Tax Income	100	66	-79	66	127	3.00	-64	9.33	-30	128	97
Total Operating Income	96	78	-46	158	164	56	124	47	57	247	226
Total Gross Profit	926	1,014	1,098	1,313	1,350	1,232	1,276	1,395	1,439	1,597	1,617
Total Revenue	1,494	1,788	2,135	2,593	2,751	2,481	2,576	2,888	3,080	3,292	3,403
Operating Revenue	1,494	1,788	2,135	2,593	2,751	2,481	2,576	2,888	3,080	3,292	3,403
Total Cost of Revenue	569	774	1,037	1,280	1,401	1,249	1,300	1,493	1,641	1,695	1,786
Operating Cost of Revenue	569	774	1,037	1,280	1,401	1,249	1,300	1,493	1,641	1,695	1,786
Total Operating Expenses	829	936	1,144	1,155	1,186	1,076	1,153	1,348	1,382	1,349	1,391
Selling, General & Admin Expense	143	146	208	177	163	183	196	197	209	206	219
Marketing Expense	472	509	611	715	714	574	648	789	774	790	814
Research & Development Expense	187	210	243	246	237	253	253	293	302	322	334
Amortization Expense	24	41	46	50	53	52	54	54	47	31	19
Impairment Charge	0.00	31	9.56	0.00	7.50	-	0.00	0.00	5.61	0.00	0.00
Restructuring Charge	3.20	0.38	27	15	12	14	1.64	14	44	0.42	5.53
Total Other Income / (Expense), net	3.43	-12	-34	-91	-37	-53	-187	-38	-88	-119	-129
Interest Expense	17	38	44	70	63	76	168	99	106	120	116
Other Income / (Expense), net	20	26	10	-21	26	23	-19	61	18	1.58	-14
Income Tax Expense	10	16	-7.12	20	33	-81	19	60	155	-49	84
Net Income / (Loss) Attributable to Noncontrolling Interest	-2.90	-3.94	-0.49	3.06	-1.57	0.63	2.77	3.76	0.26	4.13	-2.10
Basic Earnings per Share	$2.82	$1.72	($2.29)	$1.41	$3.09	$3.07	($3.28)	($2.08)	($7.08)	$6.64	$0.60
Weighted Average Basic Shares Outstanding	32.64M	31.66M	31.29M	30.95M	30.79M	27.18M	26.00M	26.09M	26.25M	26.15M	24.92M
Diluted Earnings per Share	$2.73	$1.64	($2.29)	$1.36	$3.00	$3.00	$0.00	($2.08)	($7.08)	$6.43	$0.58
Weighted Average Diluted Shares Outstanding	33.82M	33.05M	31.29M	32.22M	31.66M	27.77M	0.00	26.09M	26.25M	27.00M	25.64M
Weighted Average Basic & Diluted Shares Outstanding	32.70M	31.60M	31.30M	31M	30.80M	25.89M	25.05M	26.14M	26.36M	25.07M	24.48M

This table shows Cimpress' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	4.55	58	-3.98	115	-13	61	-8.24	-25	7.64	49	14
Consolidated Net Income / (Loss)	4.57	60	-5.18	118	-12	62	-8.02	-28	6.52	49	15
Net Income / (Loss) Continuing Operations	4.57	60	-5.18	118	-12	62	-8.02	-28	6.52	49	15
Total Pre-Tax Income	13	77	5.43	33	-3.39	83	4.12	13	24	63	26
Total Operating Income	34	108	39	66	39	81	41	65	49	88	49
Total Gross Profit	359	458	376	404	382	450	373	413	403	488	409
Total Revenue	757	921	781	833	805	939	789	869	863	1,042	886
Operating Revenue	757	921	781	833	805	939	789	869	863	1,042	886
Total Cost of Revenue	399	463	405	428	423	489	417	457	460	554	477
Operating Cost of Revenue	399	463	405	428	423	489	417	457	460	554	477
Total Operating Expenses	324	350	337	338	343	369	332	347	354	400	360
Selling, General & Admin Expense	48	49	54	54	52	57	51	59	54	60	59
Marketing Expense	192	212	192	194	204	224	193	193	210	246	209
Research & Development Expense	74	80	84	84	82	83	83	86	85	89	87
Amortization Expense	9.89	9.18	6.92	5.46	5.16	5.12	4.52	4.27	4.25	2.88	2.89
Impairment Charge	-	-	-	-	0.00	0.00	0.00	-	0.00	0.00	0.00
Restructuring Charge	-0.33	0.48	0.13	0.15	0.10	0.16	0.47	4.80	0.30	1.31	2.81
Total Other Income / (Expense), net	-21	-31	-34	-33	-43	1.82	-36	-52	-25	-25	-23
Interest Expense	28	30	30	32	31	30	27	28	28	27	25
Other Income / (Expense), net	6.42	-0.39	-3.65	-0.79	-11	32	-9.44	-24	3.45	1.73	2.58
Income Tax Expense	8.12	17	11	-85	9.00	21	12	42	18	13	12
Net Income / (Loss) Attributable to Noncontrolling Interest	0.02	2.15	-1.20	3.17	0.17	0.56	0.22	-3.04	-1.12	0.15	0.80
Basic Earnings per Share	$0.17	$2.18	($0.15)	$4.44	($0.50)	$2.45	($0.33)	($1.02)	$0.31	$2.01	$0.57
Weighted Average Basic Shares Outstanding	26.47M	26.61M	26.22M	26.15M	25.17M	24.97M	24.83M	24.92M	24.57M	24.57M	24.26M
Diluted Earnings per Share	$0.17	$2.14	($0.15)	$4.27	($0.50)	$2.36	($0.33)	($0.95)	$0.30	$1.95	$0.55
Weighted Average Diluted Shares Outstanding	27.08M	27.18M	26.22M	27.00M	25.17M	25.91M	24.83M	25.64M	25.05M	25.30M	25.19M
Weighted Average Basic & Diluted Shares Outstanding	26.59M	26.64M	25.45M	25.07M	25.15M	24.82M	24.88M	24.48M	24.67M	24.29M	24.23M

This table details how cash moves in and out of Cimpress' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Change in Cash & Equivalents	41	-26	-52	-76	-8.95	9.74	128	234	-151	73	30
Net Cash From Operating Activities	242	247	157	192	331	338	265	220	130	351	298
Net Cash From Continuing Operating Activities	262	247	157	192	331	316	251	220	130	350	298
Net Income / (Loss) Continuing Operations	89	50	-72	47	93	84	-82	-51	-186	178	13
Consolidated Net Income / (Loss)	89	50	-72	47	93	84	-82	-51	-186	178	13
Depreciation Expense	98	132	158	169	174	168	173	176	162	152	141
Non-Cash Adjustments To Reconcile Net Income	12	42	56	24	29	131	98	37	42	67	45
Changes in Operating Assets and Liabilities, net	43	23	15	-48	35	-67	62	58	111	-47	99
Net Cash From Investing Activities	-217	-266	-302	-11	-420	-67	-354	-4.00	-104	-55	-141
Net Cash From Continuing Investing Activities	-217	-266	-302	-11	-420	-67	-354	136	-104	-55	-141
Purchase of Property, Plant & Equipment	-93	-107	-111	-102	-119	-94	-99	-126	-112	-113	-153
Acquisitions	-124	-165	-205	-0.42	-290	-4.27	-53	75	-0.50	-3.62	-0.66
Purchase of Investments	-	-	-	-	-12	30	-207	0.00	-84	0.00	5.44
Sale of Property, Plant & Equipment	0.00	0.00	4.51	0.89	0.64	1.64	5.70	38	4.66	24	3.08
Divestitures	-	0.00	0.00	94	0.00	-1.12	0.00	0.00	-4.13	0.00	0.00
Sale and/or Maturity of Investments	-	-	6.35	0.00	-	0.00	0.00	149	92	39	4.50
Other Investing Activities, net	0.00	6.11	3.89	-3.06	0.35	1.56	-0.27	0.62	-0.28	0.00	0.00
Net Cash From Financing Activities	25	-5.34	105	-178	82	-258	224	-107	-177	-223	-136
Net Cash From Continuing Financing Activities	47	-5.34	105	-249	82	-258	229	-107	-177	-223	-136
Repayment of Debt	-594	-445	-556	-1,313	-967	-1,362	-1,564	-16	-107	-246	-592
Repurchase of Common Equity	0.00	-153	-50	-96	-141	-627	-5.06	-2.17	-96	-157	-82
Payment of Dividends	0.00	5.14	0.00	0.00	-3.38	-3.96	-4.75	-3.96	-3.65	-0.55	-0.82
Issuance of Debt	643	598	738	1,206	1,143	1,764	1,815	0.00	48	206	567
Issuance of Common Equity	17	4.71	6.19	12	60	22	2.28	0.00	0.33	2.10	1.38
Other Financing Activities, net	-40	-15	-34	14	-9.26	-52	-15	-84	-20	-27	-30
Effect of Exchange Rate Changes	-8.92	-2.64	0.79	2.51	-1.87	-	2.97	-15	-	-0.09	8.82
Other Net Changes in Cash	-	0.00	-12	12	0.00	-3.58	-	0.00	0.00	0.00	0.00
Cash Interest Paid	8.52	38	45	57	64	73	117	98	114	132	110
Cash Income Taxes Paid	14	20	49	32	26	14	28	33	31	49	33

This table details how cash moves in and out of Cimpress' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-3.64	148	-120	49	-51	71	-41	51	-33	58	-69
Net Cash From Operating Activities	42	175	8.43	125	4.38	177	9.70	107	25	165	-17
Net Cash From Continuing Operating Activities	42	177	8.43	125	4.64	176	9.70	107	25	165	-17
Net Income / (Loss) Continuing Operations	4.57	60	-5.18	118	-12	62	-8.02	-28	6.52	49	15
Consolidated Net Income / (Loss)	4.57	60	-5.18	118	-12	62	-8.02	-28	6.52	49	15
Depreciation Expense	40	39	37	36	36	35	34	36	37	37	37
Non-Cash Adjustments To Reconcile Net Income	5.48	13	31	20	6.59	17	12	8.36	15	20	23
Changes in Operating Assets and Liabilities, net	-7.73	64	-54	-49	-25	62	-29	91	-33	58	-92
Net Cash From Investing Activities	-11	-20	-14	-9.91	-26	-38	-41	-37	-43	-51	-39
Net Cash From Continuing Investing Activities	-11	-20	-14	-9.91	-26	-38	-41	-37	-43	-51	-39
Purchase of Property, Plant & Equipment	-37	-25	-26	-25	-32	-43	-41	-37	-44	-41	-40
Acquisitions	0.00	-	-	-3.62	0.00	-	-0.66	-	0.00	-10	-1.30
Sale of Property, Plant & Equipment	5.64	0.35	0.43	17	1.57	0.10	0.69	0.72	0.82	0.87	1.70
Other Investing Activities, net	0.00	-	-	-	0.00	-	-	-	0.00	-	0.10
Net Cash From Financing Activities	-35	-12	-110	-65	-35	-59	-13	-29	-15	-57	-8.92
Net Cash From Continuing Financing Activities	-35	-12	-110	-65	-35	-59	-13	-29	-15	-57	-8.92
Repayment of Debt	-24	-8.55	-4.11	-210	-535	-48	-4.61	-4.14	-3.92	-4.37	-5.44
Repurchase of Common Equity	0.00	-	-101	-56	-11	-46	-3.95	-21	-2.73	-48	-24
Issuance of Debt	0.17	0.35	0.37	205	525	41	0.09	0.44	0.18	0.97	2.35
Issuance of Common Equity	0.08	0.01	0.69	1.33	1.00	0.37	0.01	-	0.51	0.78	25
Other Financing Activities, net	-11	-3.90	-6.50	-4.99	-15	-6.03	-4.88	-3.96	-8.70	-6.25	-7.16
Effect of Exchange Rate Changes	-	-	-3.63	-0.71	5.71	-8.82	3.31	8.61	-1.06	0.57	-4.30
Cash Interest Paid	24	42	24	42	35	20	36	19	37	19	35
Cash Income Taxes Paid	16	11	13	10	1.83	13	9.62	12	13	8.82	14

This table presents Cimpress' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Total Assets	1,300	1,464	1,680	1,652	1,868	1,815	2,182	2,168	1,855	1,892	1,968
Total Current Assets	216	201	246	239	240	248	528	626	441	458	503
Cash & Equivalents	104	77	26	44	35	45	183	277	130	204	234
Short-Term Investments	6.91	7.89	-	-	-	0.00	152	50	39	4.50	0.00
Accounts Receivable	32	32	49	56	61	35	51	64	67	65	68
Inventories, net	18	18	47	61	66	80	70	127	108	97	113
Prepaid Expenses	55	65	79	79	78	89	73	109	97	88	87
Plant, Property, & Equipment, net	468	493	512	484	491	339	329	287	288	265	302
Total Noncurrent Assets	616	770	922	929	1,137	1,228	1,325	1,255	1,126	1,169	1,163
Long-Term Investments	-	-	-	-	-	0.00	51	0.00	4.50	0.00	0.00
Goodwill	401	466	515	521	719	622	727	767	782	787	826
Intangible Assets	173	252	324	286	333	281	274	245	205	169	163
Noncurrent Deferred & Refundable Income Taxes	17	26	48	67	60	143	150	113	13	95	61
Other Noncurrent Operating Assets	25	26	35	55	26	182	124	130	123	118	113
Total Liabilities & Shareholders' Equity	1,300	1,464	1,680	1,652	1,868	1,815	2,182	2,168	1,855	1,892	1,968
Total Liabilities	993	1,232	1,559	1,472	1,673	2,153	2,561	2,531	2,467	2,419	2,532
Total Current Liabilities	306	336	449	481	521	487	638	693	645	664	759
Short-Term Debt	21	22	29	59	81	18	9.90	10	11	12	9.09
Accounts Payable	66	87	127	152	185	164	200	314	286	327	332
Accrued Expenses	173	179	176	187	195	211	248	254	257	246	304
Current Deferred Revenue	23	26	30	28	32	39	51	59	45	46	48
Other Current Liabilities	21	23	78	55	28	55	130	56	47	33	65
Total Noncurrent Liabilities	687	897	1,110	991	1,153	1,667	1,923	1,839	1,821	1,755	1,773
Long-Term Debt	493	657	848	768	942	1,416	1,733	1,676	1,627	1,592	1,576
Noncurrent Deferred & Payable Income Tax Liabilities	48	69	61	51	45	34	27	41	47	25	23
Other Noncurrent Operating Liabilities	146	170	201	172	166	217	163	122	147	138	173
Redeemable Noncontrolling Interest	58	65	45	86	63	69	71	131	11	23	19
Total Equity & Noncontrolling Interests	249	166	75	94	132	-407	-449	-495	-623	-550	-583
Total Preferred & Common Equity	249	166	75	94	132	407	-449	-495	-623	-550	-583
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	249	166	75	94	132	-407	-449	-495	-623	-550	-583
Common Stock	325	336	362	396	412	-439	461	502	540	571	593
Retained Earnings	435	486	415	453	537	-618	530	414	235	273	225
Treasury Stock	-412	-549	-588	-686	-737	1,376	-1,369	-1,364	-1,364	-1,364	-1,364
Accumulated Other Comprehensive Income / (Loss)	-99	-108	-113	-70	-80	89	-71	-47	-35	-30	-38
Noncontrolling Interest	0.51	0.35	0.21	0.29	-	-	-	0.00	0.46	0.63	0.99

This table presents Cimpress' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/31/2022	3/31/2023	9/30/2023	12/31/2023	3/31/2024	9/30/2024	12/31/2024	3/31/2025	9/30/2025	12/31/2025	3/31/2026
Total Assets	1,952	1,893	1,809	1,948	1,784	1,884	1,918	1,878	1,967	2,094	2,055
Total Current Assets	525	470	444	578	442	428	496	444	489	561	496
Cash & Equivalents	111	115	125	274	154	153	224	183	201	258	189
Short-Term Investments	85	68	23	17	6.50	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Receivable	70	68	69	63	71	74	59	66	79	71	73
Inventories, net	141	116	114	105	96	110	103	102	119	123	124
Prepaid Expenses	118	103	113	119	114	91	109	93	91	110	110
Plant, Property, & Equipment, net	278	284	272	277	270	274	279	288	315	349	353
Total Noncurrent Assets	1,148	1,139	1,094	1,093	1,072	1,182	1,144	1,147	1,162	1,185	1,206
Long-Term Investments	17	6.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Goodwill	777	787	772	791	779	805	778	793	826	827	818
Intangible Assets	225	215	191	188	176	169	158	158	161	162	158
Noncurrent Deferred & Refundable Income Taxes	9.52	10	12	12	9.44	97	90	88	58	57	55
Other Noncurrent Operating Assets	120	120	118	102	107	111	118	108	117	139	174
Total Liabilities & Shareholders' Equity	1,952	1,893	1,809	1,948	1,784	1,884	1,918	1,878	1,967	2,094	2,055
Total Liabilities	2,553	2,543	2,412	2,487	2,408	2,430	2,453	2,415	2,519	2,618	2,509
Total Current Liabilities	697	676	639	708	636	670	728	680	755	826	730
Short-Term Debt	10	11	11	11	11	11	9.63	9.18	8.98	14	14
Accounts Payable	319	264	264	344	269	298	341	299	318	354	308
Accrued Expenses	265	300	273	265	271	267	285	273	308	353	303
Current Deferred Revenue	49	55	49	45	50	52	48	53	57	50	54
Other Current Liabilities	55	46	42	42	35	43	44	45	62	56	51
Total Noncurrent Liabilities	1,856	1,868	1,773	1,779	1,772	1,760	1,725	1,735	1,764	1,792	1,779
Long-Term Debt	1,679	1,683	1,595	1,601	1,591	1,586	1,579	1,578	1,574	1,578	1,575
Noncurrent Deferred & Payable Income Tax Liabilities	47	44	49	45	47	24	23	21	23	23	22
Other Noncurrent Operating Liabilities	130	141	129	133	134	151	123	136	167	192	182
Redeemable Noncontrolling Interest	13	12	11	13	12	24	19	20	18	6.06	70
Total Equity & Noncontrolling Interests	-613	-662	-614	-552	-635	-570	-554	-557	-571	-530	-524
Total Preferred & Common Equity	-613	-662	-614	-553	-636	-571	-554	-558	-571	-531	-524
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-613	-662	-614	-553	-636	-571	-554	-558	-571	-531	-524
Common Stock	522	530	544	561	563	574	577	586	601	609	613
Retained Earnings	256	207	240	298	206	251	278	266	231	261	256
Treasury Stock	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364
Accumulated Other Comprehensive Income / (Loss)	-28	-35	-35	-47	-41	-32	-46	-46	-39	-37	-30
Noncontrolling Interest	-	0.54	0.56	0.63	0.62	0.73	0.78	0.94	0.56	0.70	0.00

This table displays calculated financial ratios and metrics derived from Cimpress' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	17.63%	19.67%	19.43%	21.41%	6.12%	-9.80%	3.81%	12.10%	6.65%	6.89%	3.38%
EBITDA Growth	56.67%	10.40%	-47.90%	148.47%	18.99%	-32.17%	12.39%	2.55%	-16.24%	68.19%	-11.70%
EBIT Growth	81.16%	-10.45%	-133.89%	487.01%	38.98%	-58.52%	32.11%	4.42%	-30.30%	228.38%	-14.56%
NOPAT Growth	23.48%	-30.85%	-153.64%	447.75%	8.32%	1,199.06%	-94.48%	-396.49%	115.65%	753.54%	-91.24%
Net Income Growth	106.19%	-43.56%	-243.22%	164.80%	99.79%	-10.15%	-198.17%	38.67%	-267.24%	195.74%	-92.77%
EPS Growth	113.28%	-39.93%	-239.63%	159.39%	120.59%	0.00%	-100.00%	0.00%	-240.38%	190.82%	-90.98%
Operating Cash Flow Growth	57.42%	2.20%	-36.64%	22.71%	72.15%	2.22%	-21.64%	-17.23%	-40.65%	169.19%	-15.01%
Free Cash Flow Firm Growth	94.84%	-488.43%	-161.25%	158.39%	-221.08%	1,797.56%	-90.67%	-272.68%	166.80%	78.17%	-65.72%
Invested Capital Growth	15.51%	16.01%	13.28%	3.06%	22.91%	-11.25%	-6.86%	1.77%	-14.33%	1.96%	-9.39%
Revenue Q/Q Growth	2.91%	5.84%	4.15%	2.65%	1.61%	-9.01%	8.70%	3.13%	2.19%	1.35%	1.10%
EBITDA Q/Q Growth	1.73%	18.43%	-28.11%	18.08%	10.43%	-22.35%	7.23%	-4.09%	36.45%	-0.17%	-6.36%
EBIT Q/Q Growth	-1.00%	38.72%	-276.81%	53.30%	20.27%	-46.32%	17.36%	-8.34%	605.58%	1.85%	-10.30%
NOPAT Q/Q Growth	-5.07%	7.65%	-128.33%	87.33%	27.26%	646.98%	11.06%	-538.50%	341.09%	124.57%	-90.33%
Net Income Q/Q Growth	-5.88%	77.82%	-251.90%	161.18%	71.06%	-47.57%	-42.11%	41.29%	24.19%	104.33%	-91.94%
EPS Q/Q Growth	-5.86%	69.07%	-236.76%	161.54%	77.51%	-43.40%	100.00%	-182.87%	29.27%	-37.87%	-90.00%
Operating Cash Flow Q/Q Growth	-2.45%	1.03%	-10.84%	8.22%	22.55%	-13.81%	-2.97%	23.34%	-16.64%	22.01%	-5.58%
Free Cash Flow Firm Q/Q Growth	75.05%	77.25%	10.96%	-8.76%	42.28%	442.55%	-28.66%	-266.49%	-19.52%	72.66%	-57.06%
Invested Capital Q/Q Growth	32.38%	-0.70%	-4.23%	1.97%	-2.38%	-5.27%	1.43%	-9.29%	-0.10%	6.36%	-9.19%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	61.95%	56.73%	51.44%	50.64%	49.06%	49.67%	49.54%	48.30%	46.73%	48.51%	47.53%
EBITDA Margin	14.32%	13.21%	5.76%	11.79%	13.23%	9.95%	10.77%	9.85%	7.74%	12.17%	10.40%
Operating Margin	6.45%	4.37%	-2.14%	6.09%	5.95%	2.26%	4.79%	1.64%	1.86%	7.51%	6.65%
EBIT Margin	7.79%	5.83%	-1.66%	5.28%	6.91%	3.18%	4.04%	3.77%	2.46%	7.56%	6.25%
Profit (Net Income) Margin	5.98%	2.82%	-3.38%	1.80%	3.40%	3.39%	-3.20%	-1.75%	-6.03%	5.40%	0.38%
Tax Burden Percent	89.53%	76.27%	91.03%	70.50%	73.66%	2,797.04%	129.74%	-541.96%	614.50%	138.43%	13.26%
Interest Burden Percent	85.66%	63.38%	224.44%	48.52%	66.77%	3.81%	-61.02%	8.58%	-39.87%	51.60%	45.59%
Effective Tax Rate	10.47%	23.73%	0.00%	29.50%	26.34%	-2,697.04%	0.00%	641.96%	0.00%	-38.43%	86.74%
Return on Invested Capital (ROIC)	13.01%	7.77%	-3.64%	11.73%	11.23%	140.18%	8.52%	-25.98%	4.34%	39.76%	3.62%
ROIC Less NNEP Spread (ROIC-NNEP)	13.80%	5.92%	-9.35%	3.65%	8.18%	15.52%	-3.78%	-10.82%	-11.66%	28.25%	2.37%
Return on Net Nonoperating Assets (RNNOA)	19.42%	10.95%	-37.38%	19.39%	38.61%	-257.35%	14.49%	39.61%	33.75%	-71.00%	-5.98%
Return on Equity (ROE)	32.43%	18.72%	-41.02%	31.12%	49.84%	-117.17%	23.01%	13.64%	38.09%	-31.24%	-2.36%
Cash Return on Invested Capital (CROIC)	-1.39%	-7.06%	-16.09%	8.71%	-9.33%	152.10%	15.63%	-27.73%	19.78%	37.82%	13.48%
Operating Return on Assets (OROA)	10.18%	7.55%	-2.25%	8.21%	10.80%	4.28%	5.21%	5.00%	3.77%	13.29%	11.02%
Return on Assets (ROA)	7.80%	3.65%	-4.59%	2.81%	5.31%	4.56%	-4.13%	-2.33%	-9.23%	9.49%	0.67%
Return on Common Equity (ROCE)	28.34%	14.41%	-28.05%	17.45%	29.96%	-225.27%	27.52%	17.36%	43.66%	-32.20%	-2.45%
Return on Equity Simple (ROE_SIMPLE)	35.88%	30.42%	-96.27%	49.95%	70.92%	20.61%	18.35%	10.22%	29.80%	-32.32%	0.00%
Net Operating Profit after Tax (NOPAT)	86	60	-32	111	121	1,565	86	-256	40	342	30
NOPAT Margin	5.77%	3.34%	-1.50%	4.29%	4.38%	63.09%	3.36%	-8.88%	1.30%	10.40%	0.88%
Net Nonoperating Expense Percent (NNEP)	-0.79%	1.85%	5.72%	8.08%	3.05%	124.66%	12.31%	-15.16%	16.00%	11.51%	1.25%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-	2.99%
Cost of Revenue to Revenue	38.05%	43.27%	48.56%	49.36%	50.94%	50.33%	50.46%	51.70%	53.27%	51.49%	52.47%
SG&A Expenses to Revenue	9.57%	8.16%	9.72%	6.83%	5.91%	7.38%	7.60%	6.83%	6.79%	6.25%	6.42%
R&D to Revenue	12.50%	11.75%	11.39%	9.48%	8.61%	10.21%	9.82%	10.14%	9.81%	9.78%	9.82%
Operating Expenses to Revenue	55.50%	52.36%	53.58%	44.55%	43.11%	43.35%	44.74%	46.67%	44.87%	40.99%	40.88%
Earnings before Interest and Taxes (EBIT)	116	104	-35	137	190	79	104	109	76	249	213
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	214	236	123	306	364	247	277	284	238	401	354
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	0.00	0.80	1.10	0.35	0.51	0.68	0.34
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	23.70	0.00	0.00	0.00	12.84	78.20
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	4.22%	0.00%	0.00%	0.00%	7.79%	1.28%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	3.27	4.34	2.52	3.57	4.20	3.22
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	1.38	1.65	0.87	0.99	1.11	0.75
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	13.91	15.32	8.81	12.77	9.11	7.18
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	43.55	40.80	23.04	40.12	14.66	11.95
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	2.19	49.16	0.00	75.82	10.66	84.71
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	10.14	16.02	11.41	23.35	10.41	8.52
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	2.02	26.82	0.00	16.64	11.20	22.75
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.67	2.93	7.27	4.59	5.25	-4.24	-4.61	-4.64	-2.68	-3.05	-2.81
Long-Term Debt to Equity	1.61	2.84	7.03	4.26	4.83	-4.18	-4.58	-4.61	-2.66	-3.02	-2.80
Financial Leverage	1.41	1.85	4.00	5.31	4.72	-16.58	-3.83	-3.66	-2.90	-2.51	-2.52
Leverage Ratio	4.16	5.13	8.93	11.08	9.39	-25.69	-5.58	-5.87	-4.12	-3.29	-3.54
Compound Leverage Factor	3.56	3.25	20.04	5.38	6.27	-0.98	3.40	-0.50	1.64	-1.70	-1.61
Debt to Total Capital	62.60%	74.57%	87.90%	82.11%	84.00%	130.90%	127.73%	127.48%	159.62%	148.85%	155.14%
Short-Term Debt to Total Capital	2.56%	2.39%	2.90%	5.89%	6.67%	1.64%	0.73%	0.79%	1.04%	1.16%	0.89%
Long-Term Debt to Total Capital	60.04%	72.18%	85.00%	76.23%	77.33%	129.26%	127.00%	126.70%	158.58%	147.69%	154.25%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	7.09%	7.22%	4.57%	8.58%	5.19%	6.31%	5.21%	9.94%	1.11%	2.19%	1.96%
Common Equity to Total Capital	30.31%	18.21%	7.52%	9.30%	10.82%	-37.20%	-32.94%	-37.42%	-60.73%	-51.04%	-57.10%
Debt to EBITDA	2.40	2.87	7.12	2.70	2.81	5.81	6.28	5.93	6.88	4.00	4.48
Net Debt to EBITDA	1.89	2.51	6.92	2.56	2.72	5.63	4.89	4.78	6.15	3.48	3.82
Long-Term Debt to EBITDA	2.30	2.78	6.89	2.51	2.59	5.74	6.25	5.89	6.83	3.97	4.45
Debt to NOPAT	5.96	11.38	-27.40	7.43	8.49	0.92	20.15	-6.58	40.83	4.69	52.86
Net Debt to NOPAT	4.68	9.95	-26.60	7.03	8.20	0.89	15.69	-5.30	36.51	4.08	45.05
Long-Term Debt to NOPAT	5.72	11.01	-26.50	6.90	7.82	0.90	20.04	-6.54	40.56	4.65	52.55
Altman Z-Score	0.00	0.00	0.00	0.00	0.00	1.43	2.28	1.97	2.22	2.80	2.37
Noncontrolling Interest Sharing Ratio	12.60%	23.01%	31.61%	43.91%	39.89%	-92.27%	-19.57%	-27.32%	-14.65%	-3.07%	-4.01%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.71	0.60	0.55	0.50	0.46	0.51	0.83	0.90	0.68	0.69	0.66
Quick Ratio	0.47	0.35	0.17	0.21	0.18	0.16	0.60	0.56	0.37	0.41	0.40
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-9.21	-54	-142	83	-100	1,699	158	-274	183	326	112
Operating Cash Flow to CapEx	259.86%	231.70%	146.55%	190.63%	279.23%	364.64%	282.86%	247.79%	121.88%	391.13%	198.66%
Free Cash Flow to Firm to Interest Expense	-0.55	-1.42	-3.22	1.17	-1.58	22.40	0.95	-2.75	1.72	2.70	0.96
Operating Cash Flow to Interest Expense	14.49	6.48	3.56	2.73	5.24	4.46	1.58	2.21	1.23	2.91	2.58
Operating Cash Flow Less CapEx to Interest Expense	8.91	3.68	1.13	1.30	3.36	3.24	1.02	1.32	0.22	2.17	1.28
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.31	1.29	1.36	1.56	1.56	1.35	1.29	1.33	1.53	1.76	1.76
Accounts Receivable Turnover	53.69	55.47	52.75	49.74	47.32	52.11	60.42	50.41	46.93	49.90	51.23
Inventory Turnover	37.29	42.41	32.06	23.88	22.08	17.05	17.31	15.17	13.99	16.55	17.02
Fixed Asset Turnover	3.65	3.72	4.25	5.21	5.65	5.98	7.72	9.38	10.72	11.91	11.99
Accounts Payable Turnover	9.58	10.14	9.69	9.15	8.30	7.16	7.15	5.81	5.47	5.54	5.42
Days Sales Outstanding (DSO)	6.80	6.58	6.92	7.34	7.71	7.00	6.04	7.24	7.78	7.31	7.13
Days Inventory Outstanding (DIO)	9.79	8.61	11.38	15.28	16.53	21.41	21.09	24.06	26.09	22.06	21.45
Days Payable Outstanding (DPO)	38.08	35.99	37.67	39.90	43.96	51.00	51.07	62.79	66.69	65.94	67.33
Cash Conversion Cycle (CCC)	-21.50	-20.80	-19.37	-17.28	-19.72	-22.59	-23.93	-31.49	-32.82	-36.57	-38.75
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	711	825	934	963	1,183	1,050	978	996	853	870	788
Invested Capital Turnover	2.25	2.33	2.43	2.73	2.56	2.22	2.54	2.93	3.33	3.82	4.11
Increase / (Decrease) in Invested Capital	95	114	110	29	221	-133	-72	17	-143	17	-82
Enterprise Value (EV)	0.00	0.00	0.00	0.00	0.00	3,433	4,250	2,506	3,042	3,649	2,541
Market Capitalization	0.00	0.00	0.00	0.00	0.00	1,976	2,822	1,016	1,566	2,230	1,169
Book Value per Share	$7.59	$5.27	$2.41	$3.05	$4.29	($15.75)	($17.26)	($18.96)	($23.67)	($21.62)	($23.45)
Tangible Book Value per Share	($9.90)	($17.56)	($24.54)	($23.23)	($29.95)	($50.62)	($55.73)	($57.72)	($61.13)	($59.17)	($63.22)
Total Capital	821	910	997	1,007	1,219	1,095	1,364	1,323	1,026	1,078	1,022
Total Debt	514	679	877	827	1,024	1,434	1,742	1,686	1,638	1,604	1,585
Total Long-Term Debt	493	657	848	768	942	1,416	1,733	1,676	1,627	1,592	1,576
Net Debt	404	593	851	783	988	1,389	1,356	1,359	1,465	1,396	1,351
Capital Expenditures (CapEx)	93	107	107	101	119	93	94	89	107	90	150
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-179	-199	-200	-227	-234	-265	-435	-383	-362	-402	-481
Debt-free Net Working Capital (DFNWC)	-69	-113	-175	-182	-199	-220	-100	-56	-194	-193	-247
Net Working Capital (NWC)	-90	-135	-203	-242	-280	-238	-110	-66	-204	-206	-256
Net Nonoperating Expense (NNE)	-3.07	9.23	40	64	27	1,481	169	-206	226	165	17
Net Nonoperating Obligations (NNO)	404	593	813	783	988	1,389	1,356	1,359	1,465	1,396	1,351
Total Depreciation and Amortization (D&A)	98	132	158	169	174	168	173	176	162	152	141
Debt-free, Cash-free Net Working Capital to Revenue	-11.98%	-11.11%	-9.38%	-8.74%	-8.52%	-10.70%	-16.89%	-13.26%	-11.77%	-12.21%	-14.13%
Debt-free Net Working Capital to Revenue	-4.59%	-6.34%	-8.17%	-7.04%	-7.24%	-8.88%	-3.87%	-1.93%	-6.29%	-5.88%	-7.26%
Net Working Capital to Revenue	-6.00%	-7.56%	-9.53%	-9.32%	-10.19%	-9.61%	-4.26%	-2.29%	-6.63%	-6.26%	-7.52%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.82	$1.72	($2.29)	$1.41	$3.09	$3.07	($2.99)	($2.08)	($7.08)	$6.64	$0.60
Adjusted Weighted Average Basic Shares Outstanding	32.64M	31.66M	31.29M	30.95M	30.79M	27.18M	26.00M	26.09M	26.25M	26.15M	24.92M
Adjusted Diluted Earnings per Share	$2.73	$1.64	($2.29)	$1.36	$3.00	$3.00	($2.99)	($2.08)	$0.00	$6.43	$0.58
Adjusted Weighted Average Diluted Shares Outstanding	33.82M	33.05M	31.29M	32.22M	31.66M	27.77M	26.00M	26.09M	0.00	27.00M	25.64M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$3.09	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.45M	31.59M	31.30M	30.89M	30.39M	25.89M	25.05M	26.14M	26.36M	25.07M	24.48M
Normalized Net Operating Profit after Tax (NOPAT)	89	83	-6.61	88	135	49	88	43	75	173	162
Normalized NOPAT Margin	5.96%	4.67%	-0.31%	3.41%	4.90%	1.96%	3.40%	1.48%	2.42%	5.27%	4.77%
Pre Tax Income Margin	6.68%	3.70%	-3.71%	2.56%	4.61%	0.12%	-2.47%	0.32%	-0.98%	3.90%	2.85%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.97	2.73	-0.80	1.94	3.01	1.04	0.62	1.09	0.72	2.07	1.84
NOPAT to Interest Expense	5.16	1.56	-0.73	1.58	1.91	20.64	0.52	-2.58	0.38	2.84	0.26
EBIT Less CapEx to Interest Expense	1.40	-0.06	-3.24	0.51	1.13	-0.18	0.06	0.20	-0.29	1.32	0.54
NOPAT Less CapEx to Interest Expense	-0.41	-1.23	-3.16	0.15	0.03	19.42	-0.04	-3.47	-0.63	2.10	-1.04
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	-10.20%	0.00%	0.00%	3.61%	4.71%	-5.76%	-7.84%	-1.97%	0.31%	6.39%
Augmented Payout Ratio	0.00%	294.23%	-69.26%	204.87%	154.54%	751.25%	-11.90%	-12.12%	-53.43%	88.63%	643.12%

This table displays calculated financial ratios and metrics derived from Cimpress' official financial filings.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	24,285,192.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	24,285,192.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0.57
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.66%	9.01%	5.18%	5.55%	6.30%	1.93%	1.14%	4.43%	7.24%	10.97%	12.25%
EBITDA Growth	59.73%	156.53%	151.15%	-0.66%	-21.21%	1.00%	-9.99%	-23.73%	40.46%	-14.47%	36.32%
EBIT Growth	329.68%	562.84%	428.90%	7.42%	-31.27%	4.98%	-12.61%	-37.27%	88.26%	-20.25%	66.40%
NOPAT Growth	197.61%	258.26%	-338.58%	521.03%	124.31%	-28.44%	-110.55%	-158.54%	-52.40%	15.15%	134.65%
Net Income Growth	118.47%	143.49%	89.60%	331.64%	-371.04%	2.26%	-54.80%	-124.00%	152.65%	-19.68%	282.58%
EPS Growth	117.53%	140.07%	92.02%	284.68%	-394.12%	10.28%	-120.00%	-122.25%	160.00%	-17.37%	266.67%
Operating Cash Flow Growth	267.34%	115.65%	-33.11%	102.37%	-89.62%	0.90%	15.05%	-14.09%	471.60%	-6.72%	-270.42%
Free Cash Flow Firm Growth	367.11%	8.98%	-100.54%	21.17%	-107.56%	-92.73%	-10,025.04%	-125.69%	664.75%	596.25%	60.27%
Invested Capital Growth	-17.00%	-10.63%	-4.24%	1.96%	4.88%	6.06%	6.12%	-9.39%	-7.46%	-2.45%	9.05%
Revenue Q/Q Growth	-4.00%	21.67%	-15.28%	6.66%	-3.32%	16.67%	-15.94%	10.14%	-0.71%	20.73%	-14.97%
EBITDA Q/Q Growth	-21.02%	81.92%	-50.36%	39.28%	-37.36%	133.21%	-55.76%	18.02%	15.36%	42.00%	-29.49%
EBIT Q/Q Growth	-33.59%	164.78%	-66.83%	84.17%	-57.51%	304.45%	-72.39%	32.20%	27.51%	71.34%	-42.39%
NOPAT Q/Q Growth	-67.63%	585.91%	-144.47%	729.05%	-88.31%	118.84%	-230.83%	-74.91%	109.51%	429.40%	-60.63%
Net Income Q/Q Growth	-83.31%	1,218.76%	-108.60%	2,380.76%	-110.48%	597.54%	-113.02%	-253.60%	122.99%	659.05%	-70.41%
EPS Q/Q Growth	-84.68%	1,158.82%	-107.01%	2,946.67%	-111.71%	572.00%	-113.98%	-187.88%	131.58%	550.00%	-71.79%
Operating Cash Flow Q/Q Growth	-31.64%	314.03%	-95.18%	1,384.45%	-96.50%	3,926.44%	-94.51%	1,008.53%	-76.68%	557.09%	-110.03%
Free Cash Flow Firm Q/Q Growth	3.78%	-5.45%	-100.72%	17,297.90%	-106.47%	190.94%	-1,099.82%	56.36%	242.33%	12.12%	-157.05%
Invested Capital Q/Q Growth	0.28%	-8.56%	4.53%	6.36%	3.15%	-7.53%	4.59%	-9.19%	5.35%	-2.52%	16.93%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	47.34%	49.70%	48.16%	48.57%	47.48%	47.90%	47.18%	47.48%	46.66%	46.80%	46.17%
EBITDA Margin	10.62%	15.89%	9.31%	12.15%	7.88%	15.74%	8.28%	8.88%	10.31%	12.13%	10.06%
Operating Margin	4.50%	11.69%	5.03%	7.97%	4.89%	8.62%	5.14%	7.53%	5.67%	8.45%	5.55%
EBIT Margin	5.35%	11.64%	4.56%	7.87%	3.46%	11.99%	3.94%	4.73%	6.07%	8.62%	5.84%
Profit (Net Income) Margin	0.60%	6.54%	-0.66%	14.19%	-1.54%	6.56%	-1.02%	-3.26%	0.76%	4.75%	1.65%
Tax Burden Percent	36.00%	78.20%	-95.43%	355.10%	365.42%	74.44%	-194.47%	-210.72%	26.77%	78.77%	55.57%
Interest Burden Percent	31.32%	71.82%	15.26%	50.77%	-12.17%	73.49%	13.26%	32.73%	46.46%	69.94%	50.92%
Effective Tax Rate	64.00%	21.80%	195.43%	-255.10%	0.00%	25.56%	294.47%	310.72%	73.23%	21.23%	44.43%
Return on Invested Capital (ROIC)	5.39%	35.40%	-18.65%	108.14%	13.04%	26.74%	-39.90%	-65.13%	6.09%	28.97%	12.45%
ROIC Less NNEP Spread (ROIC-NNEP)	4.85%	33.69%	-16.46%	99.94%	10.29%	26.84%	-34.92%	-57.16%	5.62%	27.49%	11.54%
Return on Net Nonoperating Assets (RNNOA)	-14.18%	-82.70%	38.06%	-251.15%	-25.98%	-67.12%	85.65%	144.07%	-14.46%	-70.04%	-32.68%
Return on Equity (ROE)	-8.79%	-47.29%	19.41%	-143.00%	-12.94%	-40.39%	45.75%	78.94%	-8.37%	-41.07%	-20.23%
Cash Return on Invested Capital (CROIC)	26.70%	21.98%	22.58%	37.82%	36.51%	32.63%	30.86%	13.48%	14.71%	8.04%	0.59%
Operating Return on Assets (OROA)	8.58%	19.17%	8.05%	13.83%	6.26%	20.83%	7.24%	8.34%	10.92%	15.31%	10.87%
Return on Assets (ROA)	0.97%	10.76%	-1.17%	24.94%	-2.78%	11.40%	-1.87%	-5.75%	1.36%	8.44%	3.08%
Return on Common Equity (ROCE)	-10.06%	-48.40%	19.79%	-147.40%	-13.34%	-41.65%	47.08%	82.10%	-8.70%	-42.08%	-22.09%
Return on Equity Simple (ROE_SIMPLE)	25.47%	-7.67%	-13.68%	0.00%	-28.17%	-29.26%	-28.59%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	12	84	-37	236	28	60	-79	-138	13	69	27
NOPAT Margin	1.62%	9.14%	-4.80%	28.29%	3.42%	6.42%	-9.99%	-15.86%	1.52%	6.66%	3.08%
Net Nonoperating Expense Percent (NNEP)	0.54%	1.71%	-2.19%	8.21%	2.75%	-0.10%	-4.98%	-7.97%	0.47%	1.48%	0.90%
Return On Investment Capital (ROIC_SIMPLE)	-	7.94%	-	-	-	5.82%	-7.65%	-13.75%	1.30%	6.54%	2.57%
Cost of Revenue to Revenue	52.66%	50.30%	51.84%	51.43%	52.52%	52.10%	52.82%	52.52%	53.34%	53.20%	53.83%
SG&A Expenses to Revenue	6.38%	5.30%	6.95%	6.53%	6.45%	6.06%	6.40%	6.80%	6.25%	5.78%	6.65%
R&D to Revenue	9.82%	8.68%	10.73%	10.08%	10.17%	8.82%	10.53%	9.91%	9.83%	8.55%	9.80%
Operating Expenses to Revenue	42.84%	38.02%	43.13%	40.61%	42.60%	39.29%	42.05%	39.95%	40.99%	38.34%	40.63%
Earnings before Interest and Taxes (EBIT)	41	107	36	66	28	113	31	41	52	90	52
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	80	146	73	101	63	148	65	77	89	126	89
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.59	0.66	0.73	0.68	0.61	0.54	0.33	0.34	0.45	0.46	0.48
Price to Earnings (P/E)	0.00	50.53	26.95	12.84	13.11	11.31	7.23	78.20	43.92	70.13	38.96
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	1.98%	3.71%	7.79%	7.63%	8.84%	13.83%	1.28%	2.28%	1.43%	2.57%
Enterprise Value to Invested Capital (EV/IC)	3.88	4.43	4.66	4.20	3.93	3.84	2.94	3.22	3.55	3.69	3.43
Enterprise Value to Revenue (EV/Rev)	1.06	1.08	1.17	1.11	1.05	0.95	0.76	0.75	0.85	0.84	0.89
Enterprise Value to EBITDA (EV/EBITDA)	12.35	9.68	9.50	9.11	9.18	8.28	6.74	7.18	7.76	8.33	8.49
Enterprise Value to EBIT (EV/EBIT)	31.01	17.49	15.59	14.66	14.90	13.19	10.74	11.95	12.41	13.91	13.79
Enterprise Value to NOPAT (EV/NOPAT)	43.30	38.88	25.00	10.66	9.74	10.27	8.22	84.71	49.02	65.49	38.69
Enterprise Value to Operating Cash Flow (EV/OCF)	16.76	11.88	13.26	10.41	11.26	10.14	8.07	8.52	9.24	9.72	11.55
Enterprise Value to Free Cash Flow (EV/FCFF)	13.17	19.02	20.20	11.20	11.01	12.13	9.80	22.75	23.19	45.28	610.76
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-2.66	-2.99	-2.57	-3.05	-2.92	-2.97	-2.96	-2.81	-2.87	-3.04	-3.50
Long-Term Debt to Equity	-2.65	-2.97	-2.55	-3.02	-2.90	-2.95	-2.94	-2.80	-2.85	-3.01	-3.47
Financial Leverage	-2.92	-2.45	-2.31	-2.51	-2.52	-2.50	-2.45	-2.52	-2.57	-2.55	-2.83
Leverage Ratio	-3.99	-3.42	-2.89	-3.29	-3.21	-3.60	-3.16	-3.54	-3.50	-3.79	-3.97
Compound Leverage Factor	-1.25	-2.46	-0.44	-1.67	0.39	-2.65	-0.42	-1.16	-1.63	-2.65	-2.02
Debt to Total Capital	160.10%	150.17%	163.70%	148.85%	152.03%	150.76%	151.09%	155.14%	153.60%	149.10%	139.99%
Short-Term Debt to Total Capital	1.08%	1.03%	1.12%	1.16%	1.00%	0.91%	0.87%	0.89%	0.87%	1.27%	1.22%
Long-Term Debt to Total Capital	159.01%	149.13%	162.59%	147.69%	151.03%	149.85%	150.22%	154.25%	152.73%	147.83%	138.77%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.14%	1.31%	1.30%	2.19%	2.35%	1.85%	1.98%	1.96%	1.84%	0.63%	6.19%
Common Equity to Total Capital	-61.23%	-51.47%	-65.01%	-51.04%	-54.39%	-52.61%	-53.07%	-57.10%	-55.43%	-49.73%	-46.17%
Debt to EBITDA	5.98	4.51	3.99	4.00	4.16	4.13	4.20	4.48	4.17	4.44	4.16
Net Debt to EBITDA	5.43	3.69	3.59	3.48	3.76	3.54	3.72	3.82	3.64	3.72	3.67
Long-Term Debt to EBITDA	5.94	4.48	3.96	3.97	4.13	4.10	4.18	4.45	4.15	4.41	4.13
Debt to NOPAT	20.97	18.10	10.50	4.69	4.41	5.12	5.12	52.86	26.35	34.94	18.96
Net Debt to NOPAT	19.04	14.82	9.45	4.08	3.99	4.40	4.53	45.05	23.01	29.27	16.70
Long-Term Debt to NOPAT	20.83	17.97	10.43	4.65	4.39	5.09	5.09	52.55	26.20	34.64	18.79
Altman Z-Score	2.32	2.48	2.51	2.48	2.36	2.44	2.17	2.08	2.22	2.24	2.33
Noncontrolling Interest Sharing Ratio	-14.41%	-2.33%	-1.99%	-3.07%	-3.14%	-3.12%	-2.89%	-4.01%	-3.97%	-2.48%	-9.19%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.69	0.82	0.70	0.69	0.64	0.68	0.65	0.66	0.65	0.68	0.68
Quick Ratio	0.34	0.50	0.36	0.41	0.34	0.39	0.37	0.40	0.37	0.40	0.36
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	187	177	-1.27	219	-14	13	-129	-56	80	90	-51
Operating Cash Flow to CapEx	134.88%	700.20%	33.61%	1,510.08%	14.61%	410.54%	23.97%	293.70%	58.52%	408.26%	-43.37%
Free Cash Flow to Firm to Interest Expense	6.74	5.86	-0.04	6.78	-0.45	0.43	-4.78	-2.03	2.85	3.32	-2.02
Operating Cash Flow to Interest Expense	1.52	5.79	0.28	3.88	0.14	5.91	0.36	3.89	0.89	6.10	-0.65
Operating Cash Flow Less CapEx to Interest Expense	0.39	4.96	-0.55	3.62	-0.82	4.47	-1.14	2.56	-0.63	4.61	-2.15
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.60	1.65	1.77	1.76	1.81	1.74	1.84	1.76	1.80	1.78	1.86
Accounts Receivable Turnover	44.95	48.03	46.76	49.90	46.82	55.00	49.06	51.23	45.40	55.06	52.75
Inventory Turnover	12.42	13.62	15.79	16.55	15.32	16.78	17.73	17.02	15.86	16.71	17.27
Fixed Asset Turnover	11.52	11.56	11.72	11.91	12.24	12.09	12.07	11.99	11.74	11.37	11.43
Accounts Payable Turnover	6.05	5.04	6.30	5.54	6.12	5.10	6.19	5.42	5.92	5.44	6.42
Days Sales Outstanding (DSO)	8.12	7.60	7.81	7.31	7.80	6.64	7.44	7.13	8.04	6.63	6.92
Days Inventory Outstanding (DIO)	29.38	26.80	23.11	22.06	23.83	21.75	20.59	21.45	23.01	21.85	21.14
Days Payable Outstanding (DPO)	60.32	72.42	57.93	65.94	59.65	71.64	58.99	67.33	61.62	67.11	56.88
Cash Conversion Cycle (CCC)	-22.83	-38.02	-27.01	-36.57	-28.03	-43.25	-30.97	-38.75	-30.57	-38.64	-28.82
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	855	782	818	870	897	829	868	788	830	809	946
Invested Capital Turnover	3.32	3.87	3.89	3.82	3.81	4.17	4.00	4.11	4.01	4.35	4.04
Increase / (Decrease) in Invested Capital	-175	-93	-36	17	42	47	50	-82	-67	-20	79
Enterprise Value (EV)	3,315	3,463	3,811	3,649	3,521	3,188	2,548	2,541	2,945	2,983	3,243
Market Capitalization	1,846	2,129	2,358	2,230	2,053	1,804	1,123	1,169	1,543	1,643	1,773
Book Value per Share	($23.30)	($20.78)	($23.88)	($21.62)	($22.78)	($22.04)	($22.46)	($23.45)	($23.33)	($21.51)	($21.58)
Tangible Book Value per Share	($59.85)	($57.61)	($59.74)	($59.17)	($61.64)	($59.24)	($60.77)	($63.22)	($63.65)	($61.57)	($61.77)
Total Capital	1,003	1,074	978	1,078	1,050	1,054	1,051	1,022	1,031	1,067	1,135
Total Debt	1,606	1,612	1,602	1,604	1,596	1,589	1,587	1,585	1,583	1,591	1,589
Total Long-Term Debt	1,595	1,601	1,591	1,592	1,586	1,579	1,578	1,576	1,574	1,578	1,575
Net Debt	1,458	1,321	1,441	1,396	1,443	1,364	1,404	1,351	1,382	1,333	1,400
Capital Expenditures (CapEx)	31	25	25	8.28	30	43	40	37	43	40	38
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-332	-410	-344	-402	-385	-447	-410	-481	-457	-509	-409
Debt-free Net Working Capital (DFNWC)	-184	-119	-183	-193	-232	-223	-227	-247	-256	-251	-220
Net Working Capital (NWC)	-195	-130	-194	-206	-242	-232	-236	-256	-265	-265	-234
Net Nonoperating Expense (NNE)	7.71	24	-32	117	40	-1.35	-71	-110	6.59	20	13
Net Nonoperating Obligations (NNO)	1,458	1,321	1,441	1,396	1,443	1,364	1,404	1,351	1,382	1,333	1,400
Total Depreciation and Amortization (D&A)	40	39	37	36	36	35	34	36	37	37	37
Debt-free, Cash-free Net Working Capital to Revenue	-10.60%	-12.78%	-10.58%	-12.21%	-11.52%	-13.31%	-12.17%	-14.13%	-13.20%	-14.29%	-11.18%
Debt-free Net Working Capital to Revenue	-5.88%	-3.69%	-5.63%	-5.88%	-6.94%	-6.63%	-6.74%	-7.26%	-7.41%	-7.05%	-6.02%
Net Working Capital to Revenue	-6.23%	-4.04%	-5.96%	-6.26%	-7.25%	-6.91%	-7.01%	-7.52%	-7.67%	-7.43%	-6.40%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.17	$2.18	($0.15)	$4.44	($0.50)	$2.45	($0.33)	($1.02)	$0.31	$2.01	$0.57
Adjusted Weighted Average Basic Shares Outstanding	26.47M	26.61M	26.22M	26.15M	25.17M	24.97M	24.83M	24.92M	24.57M	24.57M	24.26M
Adjusted Diluted Earnings per Share	$0.17	$2.14	($0.15)	$4.27	($0.50)	$2.36	($0.33)	($0.95)	$0.30	$1.95	$0.55
Adjusted Weighted Average Diluted Shares Outstanding	27.08M	27.18M	26.22M	27.00M	25.17M	25.91M	24.83M	25.64M	25.05M	25.30M	25.19M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	26.59M	26.64M	25.45M	25.07M	25.15M	24.82M	24.88M	24.48M	24.67M	24.29M	24.23M
Normalized Net Operating Profit after Tax (NOPAT)	24	85	28	47	28	60	29	49	34	70	29
Normalized NOPAT Margin	3.12%	9.18%	3.53%	5.59%	3.43%	6.43%	3.64%	5.65%	4.00%	6.76%	3.26%
Pre Tax Income Margin	1.68%	8.36%	0.70%	4.00%	-0.42%	8.81%	0.52%	1.55%	2.82%	6.03%	2.97%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.46	3.55	1.18	2.03	0.89	3.77	1.15	1.49	1.87	3.33	2.04
NOPAT to Interest Expense	0.44	2.78	-1.24	7.30	0.88	2.02	-2.92	-4.99	0.47	2.57	1.08
EBIT Less CapEx to Interest Expense	0.33	2.72	0.35	1.77	-0.07	2.33	-0.35	0.16	0.34	1.83	0.54
NOPAT Less CapEx to Interest Expense	-0.68	1.96	-2.07	7.04	-0.08	0.58	-4.42	-6.31	-1.06	1.08	-0.42
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-2.69%	1.30%	0.63%	0.31%	0.51%	0.51%	0.52%	6.39%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-63.79%	1.30%	116.46%	88.63%	104.75%	132.49%	74.08%	643.12%	232.83%	385.14%	225.43%

Financials Breakdown Chart

Key Financial Trends

Here are the most relevant takeaways from Cimpress (CMPR) based on the last four years of quarterly cash flow, income statement, and balance sheet data provided.

Q2 2026 revenue rose to about $1,042.2 million, signaling a rebound in top-line activity.
Q2 2026 net income attributable to common shareholders was $49.34 million, marking a positive quarterly profit for shareholders.
Q2 2026 basic earnings per share (EPS) was $2.01, indicating meaningful quarterly profitability per share.
Q2 2026 net cash from continuing operating activities was $164.66 million, showing strong cash generation from core operations.
Q2 2026 net change in cash & equivalents was a gain of $57.53 million, boosting near-term liquidity.
Over the four-year window, revenue has fluctuated within a broad range (roughly $0.83B to $1.04B per quarter), indicating notable seasonality/volatility.
Cash and cash equivalents stood at about $258.04 million at the end of Q2 2026, providing a moderate liquidity cushion.
Long-term debt remained sizable, around $1.58 billion as of Q2 2026, contributing to a relatively high leverage profile.
Balance sheet shows negative equity in multiple quarters (Total Common Equity around -$530.7 million in Q2 2026), reflecting substantial accumulated losses and treasury activity.
Profitability has been volatile in 2025, with quarters posting losses (for example, Q4 2025 net income -$28.36 million; Q3 2025 -$8.02 million), and financing outflows remaining sizable in several periods.

05/07/26 02:00 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Cimpress' Financials

When does Cimpress' fiscal year end?

According to the most recent income statement we have on file, Cimpress' financial year ends in June. Their financial year 2025 ended on June 30, 2025.

How has Cimpress' net income changed over the last 10 years?

Cimpress' net income appears to be on a downward trend, with a most recent value of $12.85 million in 2025, falling from $89.31 million in 2015. The previous period was $177.81 million in 2024. See Cimpress' forecast for analyst expectations on whatâ€™s next for the company.

What is Cimpress' operating income?

Cimpress' total operating income in 2025 was $226.27 million, based on the following breakdown:

Total Gross Profit: $1.62 billion
Total Operating Expenses: $1.39 billion

How has Cimpress' revenue changed over the last 10 years?

Over the last 10 years, Cimpress' total revenue changed from $1.49 billion in 2015 to $3.40 billion in 2025, a change of 127.8%.

How much debt does Cimpress have?

Cimpress' total liabilities were at $2.53 billion at the end of 2025, a 4.7% increase from 2024, and a 155.0% increase since 2015.

How much cash does Cimpress have?

In the past 10 years, Cimpress' cash and equivalents has ranged from $25.70 million in 2017 to $277.05 million in 2022, and is currently $233.98 million as of their latest financial filing in 2025.

How has Cimpress' book value per share changed over the last 10 years?

Over the last 10 years, Cimpress' book value per share changed from 7.59 in 2015 to -23.45 in 2025, a change of -409.1%.

Related Companies

Financial statements for NASDAQ:CMPR last updated on 5/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cimpress (CMPR) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Cimpress' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cimpress (CMPR) Financials

Annual Income Statements for Cimpress

Quarterly Income Statements for Cimpress

Annual Cash Flow Statements for Cimpress

Quarterly Cash Flow Statements for Cimpress

Annual Balance Sheets for Cimpress

Quarterly Balance Sheets for Cimpress

Annual Metrics And Ratios for Cimpress

Quarterly Metrics And Ratios for Cimpress

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Cimpress' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools